First anticholinergic drug to treat schizophrenia approved.
Diane S Aschenbrenner
Author Information
- Diane S Aschenbrenner: Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch: diane.aschenbrenner@gmail.com.
No abstract text available.
- National Institute of Mental Health. Schizophrenia: what is schizophrenia? Updated April 2024. https://www.nimh.nih.gov/health/topics/schizophrenia
- American Psychiatric Association. What is schizophrenia? https://www.psychiatry.org/patients-families/schizophrenia/what-is-schizophrenia
- National Institute of Mental Health. Schizophrenia: prevalence of schizophrenia. https://www.nimh.nih.gov/health/statistics/schizophrenia#part_2543
- Brisch R, Saniotis A, Wolf R, et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014;5:47. doi:10.3389/fpsyt.2014.00047
